Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐ b ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐ b ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2

Published:2019-11-07 Issue:24 Volume:14 Page:2093-2101
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Kaieda Akira¹^ORCID,Takahashi Masashi¹^ORCID,Fukuda Hiromi¹,Okamoto Rei¹,Morimoto Shinji¹,Gotoh Masayuki¹,Miyazaki Takahiro¹,Hori Yuri¹,Unno Satoko¹,Kawamoto Tomohiro¹^ORCID,Tanaka Toshimasa¹^ORCID,Itono Sachiko¹,Takagi Terufumi¹,Sugimoto Hiroshi¹^ORCID,Okada Kengo¹,Lane Weston²,Sang Bi‐Ching²,Saikatendu Kumar²,Matsunaga Shinichiro¹,Miwatashi Seiji¹

Affiliation:

1. Pharmaceutical Research DivisionTakeda Pharmaceutical Company Limited 26-1, Muraoka-higashi 2-chome Fujisawa Kanagawa 251-8555 Japan

2. Takeda California 10410 Science Center Drive San Diego CA 92121 USA

Funder

National Institutes of Health

National Institute of General Medical Sciences

Howard Hughes Medical Institute

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.201900373

Reference33 articles.

1. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis

2. p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

3. How antirheumatic drugs protect joints from damage in rheumatoid arthritis

4. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective components and mechanism analysis of anti-platelet aggregation effect of Justicia procumbens L.;Journal of Ethnopharmacology;2022-08

2. Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation;Current Cancer Drug Targets;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3